BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780)
3,020.00
-25.00 (-0.82%)
Sep 4, 2026, 3:16 PM KST
BCWORLD PHARM. Revenue
BCWORLD PHARM. had revenue of 20.96B KRW in the quarter ending June 30, 2026, with 2.52% growth. This brings the company's revenue in the last twelve months to 80.33B, up 6.65% year-over-year. In the year 2025, BCWORLD PHARM. had annual revenue of 75.80B with 1.32% growth.
Revenue (ttm)
80.33B
Revenue Growth
+6.65%
P/S Ratio
0.38
Revenue / Employee
286.89M
Employees
280
Market Cap
30.87B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 75.80B | 985.64M | 1.32% |
| Dec 31, 2024 | 74.81B | -296.36M | -0.39% |
| Dec 31, 2023 | 75.11B | 2.41B | 3.31% |
| Dec 31, 2022 | 72.70B | 10.62B | 17.11% |
| Dec 31, 2021 | 62.08B | 5.05B | 8.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5.12T |
| Celltrion | 4.90T |
| Samsung Epis Holdings | 1.51T |
| ALTEOGEN | 254.01B |
| Aprogen Biologics | 86.18B |
| LabGenomics | 77.64B |
| METACARE CO. | 39.95B |
| Tdspharm | 32.90B |